ANVO Pharma Group, a science focused pharmaceutical group located in Canada and Vietnam, is expanding to build ANVO Laboratories Inc. here in London.
A three-stage expansion, the first phase will have ANVO making generic drugs in a 40,000 square foot facility, opening 2022. The second phase, projected for 2024, will expand their manufacturing capacity to produce injectable drugs, and the third phase (2026) will include vaccine production – all three phases resulting in several job opportunities across head office functions, production, and research and development.
Congratulations to the ANVO team for breaking ground on their new home of ANVO Laboratories Inc. Read more:
Image
Image
Image
